RTI Surgical (RTIX) has been under a strong bear grip, hence the stock is down -13.94% when compared to the S&P 500 in the past 4 weeks. However, in the near-term, buying emerged at lower levels and the stock has outperformed the S&P 500 by 6.14% in the past 1 week. The stock has risen by 6.11% in the past week indicating that the buyers are active at lower levels, but the stock is down -13.61% in the past 4 weeks.
RTI Surgical Inc. has dropped 12% during the last 3-month period . Year-to-Date the stock performance stands at -16.88%. The stock has recorded a 20-day Moving Average of 0.35% and the 50-Day Moving Average is 7.27%.
RTI Surgical (NASDAQ:RTIX): The stock opened at $3.29 on Friday but the bulls could not build on the opening and the stock topped out at $3.35 for the day. The stock traded down to $3.28 during the day, due to lack of any buying support eventually closed down at $3.30 with a loss of -0.30% for the day. The stock had closed at $3.31 on the previous day. The total traded volume was 132,479 shares.
Also, Craig-Hallum downgrades their rating on the shares of RTI Surgical (NASDAQ:RTIX). The current rating of the shares is Hold. Earlier, the shares were rated a Buy by the brokerage firm. The rating by the firm was issued on July 28, 2016.
RTI Surgical, Inc. produces orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues and improve surgical outcomes. The Company uses natural tissues, metals and synthetics process to produce its products. The Company processes donated human musculoskeletal and other tissue, including bone, cartilage, tendon, ligament, fascia lata, pericardium, sclera and dermal tissue, and bovine and porcine animal tissue in producing allograft and xenograft implants utilizing BIOCLEANSE, TUTOPLAST and CANCELLE SP sterilization processes and manufacture metal and synthetic implants for distribution to hospitals and surgeons. The Companys business has six categories: spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), surgical specialties and dental. The Company distributes its implants and services in all 50 states and in over 45 countries worldwide.